Toronto, May 29, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the submission of an application for a Licensed Dealer (LD) Permit to Health Canada in order to conduct analytical testing activities with Cannabis from Licensed Producers (LPs) and Medical Patients under the MMPR/ACMPR.

“We are excited to call ourselves an LD applicant and to have passed this milestone on our journey. We look forward to a thoughtful dialogue with Health Canada” President Thomas Fraleigh said. “I would like to thank our whole team for their diligent and attentive work putting the security proposal and operating procedures for this application together.”

In the current ACMPR regulatory landscape Cannabis testing laboratories operate under Health Canada’s Licensed Dealer framework. It has been proposed that under the yet-to-be-passed Cannabis Act that a new class of Analytical Permit will be created for Cannabis testing laboratories.

“Rather than wait for the new analytical permits to be created we chose to apply for an LD under the current rules while the government works on passing the Cannabis Act and finalizes the new process for Cannabis analytical licensing” Fraleigh said.

Health Canada requires that Licensed Producers of Cannabis conduct a number of laboratory tests on each batch of Cannabis or Cannabis-derived product. This includes potency (%THC & %CBD), pesticides, heavy metals, mycotoxins, moisture, foreign matter and a panel of tests for microbes. Under the Cannabis Act the pesticide testing portion will have to be conducted by an independent third party laboratory like Vivariant.